BNP Paribas Financial Markets’s Evotec EVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.2K Sell
13,277
-2,002
-13% -$5.79K ﹤0.01% 5027
2026
Q1
$38.2K Sell
15,279
-721
-5% -$2.32K ﹤0.01% 4836
2025
Q4
$49.3K Buy
16,000
+2,500
+19% +$8.58K ﹤0.01% 4689
2025
Q3
$49K Buy
13,500
+1,500
+13% +$5.7K ﹤0.01% 4611
2025
Q2
$50.4K Buy
12,000
+4,600
+62% +$18K ﹤0.01% 4254
2025
Q1
$24.7K Buy
7,400
+800
+12% +$3.27K ﹤0.01% 4474
2024
Q4
$27.5K Buy
+6,600
New +$27.7K ﹤0.01% 4637

Other funds holding EVO

BNP Paribas Financial Markets's EVO Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Evotec (EVO) stake by 13% in Q2 2026, selling an estimated $5.79K and leaving 13,277 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5027.

BNP Paribas Financial Markets first reported a position in EVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $50.4K in Q2 2025. 33 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

  • BNP Paribas Financial Markets held 13,277 shares of Evotec worth $37.2K as of Q2 2026.
  • BNP Paribas Financial Markets sold 2,002 Evotec shares in Q2 2026, an estimated $5.79K.
  • Evotec made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5027 holding.
  • BNP Paribas Financial Markets first reported a position in Evotec in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Evotec position peaked at $50.4K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.